Targeting Super-Enhancers as a Therapeutic Strategy for Cancer Treatment
Authors:
Open Access
- 11 April 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 10, 361
Abstract
Super-enhancers (SEs) refer to large clusters of enhancers that drive gene expressions. Recent data has provided novel insights in elucidating the roles of SEs in many diseases, including cancer. Many mechanisms involved in tumorigenesis and progression, ranging from internal gene mutation and rearrangement to external damage and inducement, have been demonstrated to be highly associated with SEs. Moreover, translocation, formation, deletion, or duplication of SEs themselves could lead to tumor development. It has been reported that various oncogenic molecules and pathways are tightly regulated by SEs. Moreover, several clinical trials on novel SEs blockers, such as BET inhibitor and CDK7i, have indicated the potential roles of SEs in cancer therapy. In this review, we highlighted the underlying mechanism of action of SEs in cancer development and the corresponding novel potential therapeutic strategies. It is speculated that targeting SEs could complement the traditional approaches and lead to more effective treatment for cancer patients.Keywords
This publication has 85 references indexed in Scilit:
- Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic LeukemiaCancer Cell, 2018
- Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET InhibitorsCancer Cell, 2018
- Targeting of super-enhancers and mutant BRAF can suppress growth of BRAF -mutant colon cancer cells via repression of MAPK signaling pathwayCancer Letters, 2017
- A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell NeoplasmCancer Cell, 2016
- CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven CancerCell, 2014
- Super-Enhancers in the Control of Cell Identity and DiseaseCell, 2013
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-EnhancersCell, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Functional and Mechanistic Diversity of Distal Transcription EnhancersCell, 2011
- Expression of a β-globin gene is enhanced by remote SV40 DNA sequencesCell, 1981